Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
Related Posts
Needham upgrades Robinhood to buy, says Trump victory will boost the stock
This financial services platform is slated for more gains under a second Trump term, according to Needham.
Wall Street kicks off December with jobs data on tap and the S&P 500 looking to enter the history books
Stocks are at or near all-time highs as investors turn the page to December, and as far as investors are concerned, there appears to be […]
Warren Buffett continued to sell down his Apple stake, cutting about a quarter in the third period
The Oracle of Omaha downsized Apple — his biggest equity holding — for a fourth quarter in a row.